Skip to main content Skip to navigation

Publications in Cancer Research

Comparison and combination of mutation and methylation-based urine tests for bladder cancer detection”, Naheema S. Gordon, Elspeth K. McGuigan, Michaela Ondasova, Jennifer Knight, Laura A. Baxter, Sascha Ott, Robert K. Hastings, Maurice P. Zeegers, Nicholas D. James, K. K. Cheng, Anshita Goel, Minghao Yu, Roland Arnold, Richard T. Bryan, Douglas G. Ward, Biomarker Research, 2024

 

Lineage skewing and genome instability underlie marrow failure in a zebrafish model of GATA2 deficiency”, Christopher B. Mahony, Lucy Copper, Pavle Vrljicak, Boris Noyvert, Chrystala Constantinidou, Sofia Browne, Yi Pan, Claire Palles, Sascha Ott, Martin R. Higgs, Rui Monteiro, Cell Reports, 2023

 

"Targeting of multiple tumor-associated antigens by individual T cell receptors during successful cancer immunotherapy”, Garry Dolton, Cristina Rius, Aaron Wall, Barbara Szomolay, Valentina Bianchi, Sarah A. E. Galloway, Md Samiul Hasan, Théo Morin, Marine E. Caillaud, Hannah L. Thomas, Sarah Theaker, Li Rong Tan, Anna Fuller, Katie Topley, Mateusz Legut, Meriem Attaf, Jade R. Hopkins, Enas Behiry, Joanna Zabkiewicz, Caroline Alvares, Angharad Lloyd, Amber Rogers, Peter Henley, Christopher Fegan, Oliver Ottmann, Stephen Man, Michael D. Crowther, Marco Donia, Inge Marie Svane, David K. Cole, Paul E. Brown, Pierre Rizkallah, Andrew K. Sewell, Cell, 2023

 

Properties of non-coding mutation hotspots as urinary biomarkers for bladder cancer”, L. Baxter, N. S. Gordon, S. Ott, J. Wang, P. Patel, A. Goel, K. Piechocki, L. Silcock, C. Sale, M. P. Zeegers, K. K. Cheng, N. D. James, The BladderPath trial management group, R. T. Bryan, D. G. Ward, Scientific Reports, 2023

 

Highly Sensitive and Specific Detection of Bladder Cancer via Targeted Ultra-deep Sequencing of Urinary DNA”, Douglas G Ward, Laura Baxter, Sascha Ott, Naheema S Gordon, Junhui Wang, Prashant Patel, Kim Piechocki, Lee Silcock, Chris Sale, Maurice P Zeegers, KK Cheng, Nicholas D James, Richard T Bryan, BladderPath Trial Management Group, European Urology Oncology, 2022

 

Urine DNA for monitoring chemoradiotherapy response in muscle-invasive bladder cancer: a pilot study”, Gordon NS, Baxter LA, Goel A, Arnold R, Kaur B, Liu W, Pirrie SJ, Hussain S, Viney R, Ford D, Zarkar A, Wood MA, Mitin T, Thompson RF, James ND, Ward DG, Bryan RT, BJU International, 2022

 

Viral molecular mimicry influences the antitumor immune response in murine and human melanoma”, Jacopo Chiaro, Henna H.E. Kasanen, Thomas Whalley, Cristian Capasso, Mikaela Gronholm, Sara Feola, Karita Peltonen, Firas Hamdan, Micaela Hernberg, Siru Makela, Hanna Karhap, Paul E. Brown, Beatriz Martins, Manlio Fusciello, Erkko O. Ylosmaki, Dario Greco, Anna S. Kreutzman, Satu Mustjoki, Barbara Szomolay, Vincenzo Cerullo, Cancer Immunology Research, 2021

 

"Fibrotic Phenotype of Peritumour Mesenteric Adipose Tissue in Human Colon Cancer: A Potential Hallmark of Metastatic Properties", Maria Tabuso, Raghu Adya, Richard Stark, Kishore Gopalakrishnan, Yee Wah Tsang, Sean James, Andrew White, Adrian Fisk, Federica Dimitri, Mark Christian, Ramesh Pulendran Arasaradnam, International Journal of Molecular Sciences, 2021